January 30, 2019
Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
Read More
January 30, 2019
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
Read More
January 30, 2019
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
Read More
January 30, 2019
Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside
Read More
January 30, 2019
Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside
Read More
January 30, 2019
Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV
Read More
January 30, 2019
Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
Read More
January 30, 2019
A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment – ADVANCE HCV Study
Read More
January 30, 2019
A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment – ADVANCE HCV Study
Read More
January 30, 2019
A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers
Read More
Load More
X